|
STRN4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.44537723403937E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.34556818412557E-12 |
| Normal-vs-Stage2 |
1.65837999999141E-05 |
| Normal-vs-Stage3 |
6.17650000034331E-07 |
| Normal-vs-Stage4 |
5.95810001335906E-09 |
| Stage1-vs-Stage2 |
3.929000E-01 |
| Stage1-vs-Stage3 |
1.188960E-01 |
| Stage1-vs-Stage4 |
9.331600E-01 |
| Stage2-vs-Stage3 |
7.766600E-01 |
| Stage2-vs-Stage4 |
4.342800E-01 |
| Stage3-vs-Stage4 |
2.213000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.15699672065261E-11 |
| Normal-vs-AfricanAmerican |
5.5643999963273E-08 |
| Normal-vs-Asian |
1.03580000132553E-08 |
| Caucasian-vs-AfricanAmerican |
2.320200E-01 |
| Caucasian-vs-Asian |
4.457200E-01 |
| AfricanAmerican-vs-Asian |
5.586000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.53700385752131E-11 |
| Normal-vs-Female |
2.02480254785087E-11 |
| Male-vs-Female |
1.618410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.78523903729911E-12 |
| Normal-vs-Age(41-60Yrs) |
2.65420019296414E-10 |
| Normal-vs-Age(61-80Yrs) |
5.65519999717878E-08 |
| Normal-vs-Age(81-100Yrs) |
1.291210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.295800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.236800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.325400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.067800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.278400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.859000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.184000E-02 |
| Classical-VS-Follicular |
2.484000E-01 |
| Classical-VS-Other |
6.799800E-01 |
| Classical-VS-Normal |
1.72528658026749E-13 |
| Tall-VS-Follicular |
1.163050E-01 |
| Tall-VS-Other |
8.200300E-02 |
| Tall-VS-Normal |
1.522640E-03 |
| Follicular-VS-Other |
4.582800E-01 |
| Follicular-VS-Normal |
6.56459999692771E-08 |
| Other-VS-Normal |
2.240700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.61399848620204E-11 |
| Normal-vs-N1 |
1.05780000003719E-06 |
| N0-vs-N1 |
8.887200E-01 |
|
|
